文章:
NF-κB亚基在癌症中的复杂多样作用
The diverse and complex roles of NF-κB subunits in cancer
原文发布日期:2012-01-19
DOI: 10.1038/nrc3204
类型: Review Article
开放获取: 否
要点:
- The nuclear factor-κB (NF-κB)–inhibitor of NF-κB kinase (IKK) pathway can promote the growth and survival of many solid and haematological maligancies and therefore has the potential to provide numerous targets for novel anticancer therapies.
- Most attention has focused on the development of IKKβ inhibitors, but it is now clear that IKKβ has many NF-κB-independent functions and its inhibition could result in undesired effects.
- Although it is apparent that NF-κB subunits have important roles in tumorigenesis and the response to cancer therapy, their individual contributions have not been clearly defined.
- The NF-κB response is highly pleiotropic and the consequences of its activation can be context dependent. NF-κB is not always tumour promoting and it can exhibit tumour suppressor-like activities.
- Crosstalk with tumour-suppressor proteins, such as p53, provides an important mechanism for regulating NF-κB activity and function in cancer. Tumour suppressors can inhibit the tumour-promoting activities of NF-κB subunits while facilitating their ability to suppress cancer progression.
- Understanding the regulation and function of the NF-κB subunits in cancer provides opportunities for the development of new therapies and allows the better use of existing drugs that affect NF-κB–IKK activity.
要点翻译:
- 核因子κB(NF-κB)–IKK激酶通路能促进多种实体瘤和血液恶性肿瘤的生长与存活,因此有望为新型抗癌疗法提供多个靶点。
- 目前研究主要聚焦于IKKβ抑制剂的开发,但现已明确IKKβ具有诸多不依赖NF-κB的功能,其抑制可能引发不良效应。
- 虽然NF-κB亚基在肿瘤发生和癌症治疗应答中具有重要作用已是不争事实,但各亚基的具体功能尚未明确。
- NF-κB应答具有高度多效性,其激活后果可能因具体情境而异。NF-κB并非始终促进肿瘤,它也能表现出类肿瘤抑制活性。
- 与p53等肿瘤抑制蛋白的交互作用,为调控NF-κB在癌症中的活性与功能提供了重要机制。肿瘤抑制蛋白可抑制NF-κB亚基的促瘤活性,同时增强其抑制癌症进展的能力。
- 理解NF-κB亚基在癌症中的调控机制与功能,不仅为开发新疗法创造机遇,也有助于更有效地运用现有影响NF-κB–IKK活性的药物。
英文摘要:
It is only recently that the full importance of nuclear factor-κB (NF-κB) signalling to cancer development has been understood. Although much attention has focused on the upstream pathways leading to NF-κB activation, it is now becoming clear that the inhibitor of NF-κB kinases (IKKs), which regulate NF-κB activation, have many independent functions in tissue homeostasis and normal immune function that could compromise the clinical utility of IKK inhibitors. Therefore, if the NF-κB pathway is to be properly exploited as a target for both anticancer and anti-inflammatory drugs, it is appropriate to reconsider the complex roles of the individual NF-κB subunits.
摘要翻译:
直到最近,人们才完全认识到核因子-κB(NF-κB)信号通路在癌症发生中的重要作用。尽管大量研究聚焦于激活NF-κB的上游通路,但现在越来越明确的是,调控NF-κB激活的NF-κB抑制因子激酶(IKKs)在组织稳态和正常免疫功能中具有许多独立功能,这可能会限制IKK抑制剂的临床应用价值。因此,如果要将NF-κB通路作为抗癌和抗炎药物的靶点进行有效利用,就有必要重新评估各个NF-κB亚基所发挥的复杂作用。
原文链接:
The diverse and complex roles of NF-κB subunits in cancer